What is the clinical and cost-effectiveness of C-reactive protein point-of-care testing to guide antibiotic prescribing in patients presenting to primary care with symptoms of lower respiratory tract infection? : in response to an enquiry from The Scottish Antimicrobial Prescribing Group (SAPG) and The Scottish Health Protection Network Public Health Microbiology Group.
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
Includes bibliographical references (pages 11-12).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 3 May, 2019)
C-reactive protein
Drugs
Antibiotics.
Respiratory infections